Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 90.93 USD 28.65%
Market Cap: 16.6B USD

Intrinsic Value

INSM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one INSM stock under the Base Case scenario is 91.11 USD. Compared to the current market price of 90.93 USD, Insmed Inc is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INSM Intrinsic Value
91.11 USD
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Insmed Inc

Valuation History Unavailable

Historical valuation for INSM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare INSM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Arikayce drives most of the company’s current revenue, leaving Insmed vulnerable to market changes or competing treatments that could quickly erode its core earnings base.

Bull Theses

Continued geographic expansion and potential label extensions for Arikayce could substantially increase its patient reach, reinforcing revenue growth and reducing the company’s reliance on additional funding.

Show More Less
How do you feel about INSM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Insmed Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Insmed Inc

Current Assets 1.4B
Cash & Short-Term Investments 1.2B
Receivables 47.7m
Other Current Assets 155.5m
Non-Current Assets 400m
PP&E 116.8m
Intangibles 193.5m
Other Non-Current Assets 89.8m
Efficiency

Free Cash Flow Analysis
Insmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Insmed Inc

Revenue
381m USD
Cost of Revenue
-89.6m USD
Gross Profit
291.5m USD
Operating Expenses
-1.2B USD
Operating Income
-859m USD
Other Expenses
-154.3m USD
Net Income
-1B USD
Fundamental Scores

INSM Profitability Score
Profitability Due Diligence

Insmed Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROE
50/100
Profitability
Score

Insmed Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

INSM Solvency Score
Solvency Due Diligence

Insmed Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
30/100
Solvency
Score

Insmed Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 99.07 USD with a low forecast of 80.8 USD and a high forecast of 114.45 USD.

Lowest
Price Target
80.8 USD
11% Downside
Average
Price Target
99.07 USD
9% Upside
Highest
Price Target
114.45 USD
26% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Insmed Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INSM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

INSM Insider Trading
Buy and sell transactions by insiders

INSM News

Other Videos
What is the Intrinsic Value of one INSM stock?

The intrinsic value of one INSM stock under the Base Case scenario is 91.11 USD.

Is INSM stock undervalued or overvalued?

Compared to the current market price of 90.93 USD, Insmed Inc is Fairly Valued.

Back to Top